Display options
Share it on

Open Rheumatol J. 2011;5:81-7. doi: 10.2174/1874312901105010081. Epub 2011 Nov 29.

Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes.

The open rheumatology journal

Wensheng Huang, Mohammed El Mabrouk, Judith Sylvester, Faramaze Dehnade, Muhammad Zafarullah

Affiliations

  1. Department of Medicine, University of Montreal and Research Center of CHUM (CRCHUM) Notre-Dame Hospital, Montreal, Quebec, H2L 4M1, Canada.

PMID: 22216069 PMCID: PMC3245407 DOI: 10.2174/1874312901105010081

Abstract

OBJECTIVE: Tissue inhibitors of metalloproteinases (TIMPs) are multi-functional proteins with matrix metalloproteinases-inhibiting activities. We studied expression of anti-inflammatory, TIMP-4 gene in human joint tissues and its regulation by arthritis-associated cytokines.

RESULTS: TIMP-4 RNA expression originating from synovial fibroblasts was significantly (2.4 fold; p<0.001) elevated in 8 osteoarthritic (OA) versus 7 non-arthritic synovial membranes. Non-arthritic and OA femoral head and knee chondrocytes displayed substantial but variably constitutive expression of the TIMP-4 mRNA. In articular chondrocytes, transforming growth factor beta (TGF-β1) and oncostatin M (OSM) upregulated TIMP-4 RNA and protein expression while interleukin-1 (IL-1β) and tumor necrosis factor alpha (TNF-α) did not, suggesting differential regulation by arthritis-associated cytokines. Interleukin 17 (IL-17) mildly induced TIMP-4 mRNA. TGF-β1 induction of TIMP-4 expression was partly inhibited by ERK pathway and Sp1 transcription factor inhibitors.

CONCLUSION: Enhanced TIMP-4 gene expression in OA synovial membranes and cartilage may be due to induction by TGF-β1, OSM and IL-17, suggesting its pathophysiological role in tissue remodeling in human joints. TGF-β1 induction of TIMP-4 expression is mediated partly by ERK pathway and Sp1 transcription factor.

Keywords: Osteoarthritis; TIMP-4; chondrocytes; cytokines.; synovium

References

  1. Biochem Biophys Res Commun. 2006 Jun 23;345(1):523-9 - PubMed
  2. Rheumatology (Oxford). 2006 Jun;45(6):669-75 - PubMed
  3. J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27 - PubMed
  4. Clin Immunol. 2005 May;115(2):118-28 - PubMed
  5. J Periodontol. 2005 Feb;76(2):229-33 - PubMed
  6. J Immunol. 1998 Nov 1;161(9):5000-7 - PubMed
  7. J Biomed Mater Res. 2001;58(6):605-12 - PubMed
  8. Ann Rheum Dis. 2004 Jan;63(1):95-7 - PubMed
  9. J Cell Biochem. 2002;85(2):295-303 - PubMed
  10. J Biol Chem. 1996 Nov 29;271(48):30375-80 - PubMed
  11. J Cell Physiol. 2005 May;203(2):345-52 - PubMed
  12. Biol Chem. 2001 Jun;382(6):987-91 - PubMed
  13. Arthritis Rheum. 2003 Feb;48(2):348-59 - PubMed
  14. Rheumatol Int. 1999;18(5-6):183-91 - PubMed
  15. Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv44-7 - PubMed
  16. Clin Orthop Relat Res. 2004 Oct;(427 Suppl):S27-36 - PubMed
  17. Gene Ther. 2003 Feb;10(3):234-42 - PubMed
  18. Rheumatol Int. 2008 Jul;28(9):845-50 - PubMed
  19. J Biol Chem. 2006 Apr 14;281(15):10337-46 - PubMed
  20. Cancer Res. 2001 Mar 15;61(6):2365-70 - PubMed
  21. Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii43-7 - PubMed
  22. Osteoarthritis Cartilage. 2004 Jan;12(1):38-45 - PubMed
  23. Arthritis Rheum. 2002 Dec;46(12):3361-8 - PubMed
  24. Osteoarthritis Cartilage. 2002 Feb;10(2):156-62 - PubMed
  25. Arthritis Rheum. 2004 Jan;50(1):131-41 - PubMed
  26. Biochem Biophys Res Commun. 1998 Nov 27;252(3):757-63 - PubMed
  27. Histochem Cell Biol. 2006 Sep;126(3):335-42 - PubMed
  28. Anal Biochem. 1987 Apr;162(1):156-9 - PubMed

Publication Types